Here's Why Inovio (INO) Could be Great Choice for a Bottom Fisher
Inovio (INO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend ...
INO-3107 shows promise in reducing surgeries for RRP patients
PLYMOUTH MEETING, Pa. - INOVIO (NASDAQ: INO), a biotechnology company with a market capitalization of approximately $69 million, has announced positive results from a Phase 1/2 clinical trial of ...
Inovio announces peer-reviewed data from phase 1/2 clinical trial with INO-307
Inovio (INO) announced that peer-reviewed data from its Phase 1/2 clinical trial with INO-3107 as a potential treatment for recurrent ...
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
This was the stock's fourth consecutive day of losses.
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
This was the stock's third consecutive day of losses.